The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcome of RAS mutated lung adenocarcinoma (ADC ) patients (pts) on standard chemotherapy (chemo) and immune checkpoint inhibitors (immuneCI).
 
Nuria Pardo Aranda
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Fiorella Ruiz
No Relationships to Disclose
 
Alex Martinez Marti
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
Travel, Accommodations, Expenses - Roche/Genentech
 
Alejandro Navarro
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Susana Cedres Perez
No Relationships to Disclose
 
Iris de la Fuente
No Relationships to Disclose
 
Neus Baste
No Relationships to Disclose
 
Ana Vivancos
Consulting or Advisory Role - AstraZeneca; Merck Serono; Novartis
 
Josep M Miquel
No Relationships to Disclose
 
Rodrigo Dienstmann
No Relationships to Disclose
 
Enriqueta Felip
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Roche/Genentech
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Roche/Genentech